Cargando…

Correction: Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-Α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines

Detalles Bibliográficos
Autores principales:	Cesaratto, Laura, Codarin, Erika, Vascotto, Carlo, Leonardi, Antonio, Kelley, Mark R., Tiribelli, Claudio, Tell, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753398/ http://dx.doi.org/10.1371/annotation/a610ee5c-525c-4d3c-b6b7-a4cde7b8db54

Ejemplares similares

Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-Α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines
por: Cesaratto, Laura, et al.
Publicado: (2013)

Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis
por: Di Maso, Vittorio, et al.
Publicado: (2015)

Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP
por: Pines, Alex, et al.
Publicado: (2005)

Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function
por: Vascotto, Carlo, et al.
Publicado: (2011)

APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival
por: Cardoso, Angelo A., et al.
Publicado: (2012)

Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells
por: Sriramajayam, Kannappan, et al.
Publicado: (2021)

APE1/Ref-1 as a Novel Target for Retinal Diseases
por: Heisel, Curtis, et al.
Publicado: (2021)

Mitochondrial translocation of APE1 relies on the MIA pathway
por: Barchiesi, Arianna, et al.
Publicado: (2015)

Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization
por: Li, Y., et al.
Publicado: (2014)

APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
por: Sahakian, Lauren, et al.
Publicado: (2023)

Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion
por: Manguinhas, Rita, et al.
Publicado: (2020)

Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy
por: Hartman, Gabriella D., et al.
Publicado: (2021)

Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice
por: Bortolussi, G, et al.
Publicado: (2015)

The Redox Function of APE1 Is Involved in the Differentiation Process of Stem Cells toward a Neuronal Cell Fate
por: Domenis, Rossana, et al.
Publicado: (2014)

APE1/Ref-1 Role in Inflammation and Immune Response
por: Oliveira, Thais Teixeira, et al.
Publicado: (2022)

Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor
por: Park, Myoung Soo, et al.
Publicado: (2016)

APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells
por: McIlwain, David W., et al.
Publicado: (2017)

Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor
por: Qian, Chengyuan, et al.
Publicado: (2014)

APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions
por: Mijit, Mahmut, et al.
Publicado: (2021)

Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells
por: Mijit, Mahmut, et al.
Publicado: (2023)

Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis
por: Jin, Seon-Ah, et al.
Publicado: (2017)

Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions
por: Fantini, Damiano, et al.
Publicado: (2010)

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
por: Shah, Fenil, et al.
Publicado: (2017)

Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival
por: Logsdon, Derek P., et al.
Publicado: (2018)

The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression
por: YANG, ZHEN, et al.
Publicado: (2014)

Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker
por: Choi, Sunga, et al.
Publicado: (2016)

Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein
por: Choi, Sunga, et al.
Publicado: (2016)

APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer
por: Shin, Ju Hyun, et al.
Publicado: (2015)

New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis
por: Chen, Wujun, et al.
Publicado: (2021)

Elevated APE1/Ref-1 Levels of Synovial Fluids in Patients with Rheumatoid Arthritis: Reflection of Disease Activity
por: Yoo, In Seol, et al.
Publicado: (2021)

Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression
por: Nassour, Hassan, et al.
Publicado: (2016)

Plasma APE1/Ref-1 Correlates with Atherosclerotic Inflammation in ApoE(−/−) Mice
por: Lee, Yu Ran, et al.
Publicado: (2020)

Bis-Cinnamamide Derivatives as APE/Ref-1 Inhibitors for the Treatment of Human Melanoma
por: Alhazmi, Razan, et al.
Publicado: (2022)

Changes in the Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1(APE1/Ref-1) Level during Cancer Surgery: An Observational Study
por: Jo, Yumin, et al.
Publicado: (2021)

Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides
por: Lau, J P, et al.
Publicado: (2004)

APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats
por: Yan, Tao, et al.
Publicado: (2018)

Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease (APE1/Ref1)
por: Jackson, Elias B., et al.
Publicado: (2005)

DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents
por: Raffoul, Julian J., et al.
Publicado: (2012)

Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer
por: Lee, Yu Ran, et al.
Publicado: (2016)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
por: Pascut, Devis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n5fd0feanukaadoq553clirkl7